Meanwhile, Western blots indicated that the combination treatment decreased the expressions of p-Smad3 and N-cadherin, increased the expression of E-cadherin, and reduced nuclear accumulation of Smad4 in tumor tissues (Figure 5D–5G). This evidence concerns the gene SMAD3 and neoplasm.